A Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of ConvitVax in Metastatic Breast Cancer

NCT06023277 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

BIOLOGICAL: ConvitVax

Sponsor

Jacinto Convit World Organization Inc.

Collaborators

[object Object]
[object Object]